The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

RSV: A vaccine targeting respiratory syncytial virus (RSV) has been approved for adults age 60 and older. Monoclonal antibody products (which are not vaccines) are also available to protect ...

Anyone 3 or older can get a flu shot, and adults 60 and older are eligible for the RSV vaccine. Rite Aid also plans to announce availability of those vaccines soon, spokesperson Catherine Carter says.

Currently, there is no vaccine that exists for RSV, and infants younger than 6 months old are too young to receive most vaccines recommended by the Centers for Disease Control and Prevention. 4.